Rhumbline Advisers »

Prelude Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $87k 20k 4.27
2023-09-30 $105k 34k 3.09
2023-06-30 $134k 30k 4.50
2022-03-31 $69k 10k 6.87
2021-09-30 $290k 9.3k 31.27
2021-06-30 $251k 8.8k 28.60
2021-03-31 $419k 9.7k 43.37
2020-12-31 $683k 9.5k 71.55